NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 27,000
-300 (-1.10%)
At close: Feb 27, 2026
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 326.48 billion as of February 27, 2026.
Market Cap
326.48B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
27,000.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 326.48B, an increase of 40.14%. That is a compound annual growth rate of 76.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 326.48B | 26.10% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.75T |
| Celltrion | 52.97T |
| ALTEOGEN | 21.55T |
| Sam Chun Dang Pharm. | 17.61T |
| Anterogen.Co.,Ltd. | 359.72B |
| Hyundai Pharmaceutical | 354.55B |
| Huons | 334.99B |
| Bioneer | 320.31B |